S, Z., J, L., S, H., F, W., & X, Z. (2018). Triphenylphosphonium and D-α-tocopheryl polyethylene glycol 1000 succinate-modified, tanshinone IIA-loaded lipid-polymeric nanocarriers for the targeted therapy of myocardial infarction. Dove Medical Press.
Cita Chicago Style (17a ed.)S, Zhang, Li J, Hu S, Wu F, y Zhang X. Triphenylphosphonium and D-α-tocopheryl Polyethylene Glycol 1000 Succinate-modified, Tanshinone IIA-loaded Lipid-polymeric Nanocarriers for the Targeted Therapy of Myocardial Infarction. Dove Medical Press, 2018.
Cita MLA (8a ed.)S, Zhang, et al. Triphenylphosphonium and D-α-tocopheryl Polyethylene Glycol 1000 Succinate-modified, Tanshinone IIA-loaded Lipid-polymeric Nanocarriers for the Targeted Therapy of Myocardial Infarction. Dove Medical Press, 2018.